Stockreport

JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]

Avidity Biosciences, Inc.  (RNA) 
PDF Novartis stated that their capital allocation priorities remain unchanged, and the company will continue to pursue value-creating bolt-on deals to strengthen its pipelin [Read more]